A Gordon syndrome mouse model has also been created with a Klhl3 mutation in the BTB domain, which should aid a better understanding of the Kelch-like 3/Cullin 3 interaction and contribute to possible future novel antihypertensive drug targets [107]. This evidence concerns the gene KLHL3 and Gordon syndrome.